Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Albendazole
- Therapeutic area
- Anti-infectives
- Drug class
- Antiparasitic medicines
- ATC
- P02CA
- Strength
- 200 mg
- Dosage form
- Suspension
- Pack
- 10ml
- Registration no.
- 031219
- Price record verified
- 2026-08-08
- Latest DRAP source check
- 2026-10-09 03:22
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →About Verpel 200 mg suspension
Verpel 200 mg suspension contains Albendazole 200 mg. It is registered with DRAP by Hizat Pharmaceutical Industry (registration no. 031219). Its official price is PKR 47.52 for a pack of 10ml. This price has applied since 4 November 2025. Verpel is also available as 200 mg tablet. 1 other brand of Albendazole 200 mg (suspension) is registered in Pakistan. Compare all brands and prices →
Other strengths of Verpel
Other brands of Albendazole 200 mg
Official price over time
No change in the official DRAP price is recorded for this pack (10ml). Current price PKR 47.52, effective 4 Nov 2025.
Cite this price history
MedInfoBase. Verpel 200 mg, 10ml: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/verpel-200-mg-031219-10ml-hizat-pharmaceutical-industry/ (accessed 9 October 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 47.52 | 2025-11-04 | 2026-08-08 | DRAP PharmaPrice Index | Current |
Other listed brands
Cite this record
Medicine record · DRAP registration 031219Price and registration data on this page were observed on 8 August 2026. Records change over time, so please cite the observation date alongside the access date.
